🤖 AI Summary
This study addresses the limitation of conventional network meta-analyses, which produce a single treatment ranking that disregards patient-level covariate heterogeneity and thus fails to support individualized decision-making. To overcome this, the authors propose a Bayesian network meta-analysis framework that incorporates treatment-by-covariate interaction terms, enabling the generation of personalized treatment hierarchies tailored to individual patient profiles. Parameter estimation and probabilistic treatment rankings are implemented via Markov chain Monte Carlo methods. The approach is applied to a dataset on treatments for major depressive disorder, demonstrating that patient covariates significantly influence relative treatment efficacy rankings. This advancement facilitates evidence-based, precision recommendations aligned with individual patient characteristics, moving beyond the constraints of a one-size-fits-all ranking paradigm.
📝 Abstract
Network Meta-Analysis (NMA) is an increasingly popular evidence synthesis tool that can provide a ranking of competing treatments, also known as a treatment hierarchy. Treatment-Covariate Interactions (TCIs) can be included in NMA models to allow relative treatment effects to vary with covariate values. We show that in an NMA model that includes TCIs, treatment hierarchies should be created with a particular covariate profile in mind. We outline the typical approach for creating a treatment hierarchy in standard Bayesian NMA and show how a treatment hierarchy for a particular covariate profile can be created from an NMA model that estimates TCIs. We demonstrate our methods using a real network of studies for treatments of major depressive disorder.